Internal Medicine, Pulmonary Disease · Minneapolis, MN
NPI
1356430284
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
2
Hospital affiliations
715 S 8th St
Minneapolis, MN, 55404
Phone (612) 873-6963
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
300 services
Medicare patients, 2024
107
Average age 63
Drug cost, 2024
$4.6M
1,362 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert R Kempainen was code 99215 (office e&m - established), 49 times for 25 patients. In total Robert R Kempainen billed 300 services in 35 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 49 | 25 | $105.75 | $5,182 |
| 99214 Office E&M - Established | Facility | 41 | 29 | $68.42 | $2,805 |
| 99291 Critical Care E&M | Facility | 30 | 17 | $158.69 | $4,761 |
| 94375 Pulmonary Function Testing | Office | 27 | 12 | $28.48 | $769 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 21 | $59.50 | $1,487 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 19 | 15 | $12.60 | $239 |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 11 | $89.45 | $1,252 |
| 99205 Office E&M - New | Facility | 11 | 11 | $130.28 | $1,433 |
By year: 2022 $44K for 470 services; 2023 $42K for 441 services; 2024 $22K for 300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert R Kempainen prescribed most often to Medicare patients was Trikafta (Elexacaftor/Tezacaftor/Ivacaft), with 117 prescriptions and refills. In total Robert R Kempainen wrote 1,362 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trikafta Elexacaftor/Tezacaftor/Ivacaft | 117 | 121 | Under 11 | $3.2M |
| Prednisone Generic | 102 | 121 | 32 | $298 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 84 | 103 | 27 | $3,813 |
| Ventolin Hfa Albuterol Sulfate | 72 | 85 | 16 | $5,392 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 68 | 76 | 15 | $49K |
| Azithromycin Generic | 58 | 71 | 12 | $1,263 |
| Montelukast Sodium Generic | 56 | 116 | 13 | $608 |
| Creon Lipase/Protease/Amylase | 54 | 64 | Under 11 | $336K |
| Incruse Ellipta Umeclidinium Bromide | 51 | 55 | Under 11 | $19K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 30 | 32 | Under 11 | $4,668 |
| Advair Hfa Fluticasone Propion/Salmeterol | 28 | 44 | Under 11 | $17K |
| Breo Ellipta Fluticasone/Vilanterol | 28 | 40 | Under 11 | $16K |
| Fluticasone Propionate Generic | 25 | 36 | Under 11 | $133 |
| Symbicort Budesonide/Formoterol Fumarate | 25 | 35 | Under 11 | $7,780 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 25 | 31 | Under 11 | $14K |
Brand drugs: 795 claims; generic drugs: - claims; opioid claims: 11.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Robert R Kempainen were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.